Competitive Benchmarking of 15 Leading Pharmaceutical Companies' Strategies for Leveraging the Medical Liaison Function in the United States: 6th Annual Update (2006 Report)
ANNUAL PROGRAM
This groundbreaking study analyzes how 15 leading pharmaceutical companies are strategically leveraging the medical liaison function. As a subscriber to this study, you will learn how to best maximize the use of this type of personnel. For each target company, the study provides the following information:
 | Strategic approach to the medical liaison function |
| Response to OIG guidelines |
| Organizational structure/reporting relationships by title |
| Distribution of personnel by business unit/therapeutic area |
| Key roles by title |
| Typical salary range by title |
| Description of incentive package by title |
| Evaluation methods |
The study also analyzes each company's philosophy about the medical liaison function, including:
| Quantitative and qualitative methods for valuing the function |
| Implications of Office of Inspector General guidelines and recent litigation on the liaison role |
* Save 5% -- Mention "PharmCast.com" when purchase.
To receive more information about the study, including a list of companies analyzed and sample pages, click on the "Request for Info" link.
 |
 |
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |